TITLE

A Response to "Major Complications Associated With Xenograft Biologic Mesh Implantation in Abdominal Wall Reconstruction" (Harth KC, Rosen MJ. Surg Innov. 2009;16:324-329) and Discussion of the MAUDE (Manufacturer and User Facility Device Experience) Database, FDA Regulation of Biologic Implants, and Evidence-Based Medicine

AUTHOR(S)
Segan, Ross David
PUB. DATE
September 2010
SOURCE
Surgical Innovation;Sep2010, Vol. 17 Issue 3, p273
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
53329971

 

Related Articles

  • Riata ICD Lead Failures. DiMarco, John P. // Clinical Cardiology Alert;Jun2012, Vol. 31 Issue 6, p46 

    The author discusses a study based on the Manufacturers And User facility Device Experience (MAUDE) database, by RG Hauser and colleagues, which concluded that Riata and Riata ST implantable cardioverter-defibrillator (ICD) leads, manufactured by St. Jude Medical, have a higher risk of high...

  • Structural Mechanics Predictions Relating to Clinical Coronary Stent Fracture in a 5 Year Period in FDA MAUDE Database. Everett, Kay; Conway, Claire; Desany, Gerard; Baker, Brian; Choi, Gilwoo; Taylor, Charles; Edelman, Elazer // Annals of Biomedical Engineering;Feb2016, Vol. 44 Issue 2, p391 

    Endovascular stents are the mainstay of interventional cardiovascular medicine. Technological advances have reduced biological and clinical complications but not mechanical failure. Stent strut fracture is increasingly recognized as of paramount clinical importance. Though consensus reigns that...

  • Biological Mesh in Hernia Repair, Abdominal Wall Defects, and Reconstruction and Treatment of Pelvic Organ Prolapse: A Review of the Clinical Evidence. PEPPAS, GEORGE; GKEGKES, IOANNIS D.; MAKRIS, MARINOS C.; FALAGAS, MATTHEW E. // American Surgeon;Nov2010, Vol. 76 Issue 11, p1290 

    The use of biological meshes seems to be an innovation that influences all surgical fields. The existing evidence indicates that biological meshes cannot only be applied on the area of hernia repair, but also on cases of abdominal reconstruction and pelvic organ prolapse treatment, especially in...

  • FDA Warning About Complications of Surgical Mesh. Clemens, Quentin // AUANews;Jan2009, Vol. 14 Issue 1, p12 

    The article focuses on the warning issued by the U.S. Food and Drug Administration (FDA) concerning the use of surgical mesh in treating pelvic organ prolapse and stress urinary incontinence (SUI). Based on the data from the FDA Manufacturers and User Facility Device Experience (MAUDE) database,...

  • Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review. Shah, Hemendra N.; Badlani, Gopal H. // Indian Journal of Urology;Apr-Jun2012, Vol. 28 Issue 2, p129 

    We reviewed the incidence, predisposing factors, presentation and management of complications related to the use of synthetic mesh in the management of stress urinary incontinence and pelvic organ prolapse repair. Immediate complications, such as bleeding, hematoma, injury to adjacent organs...

  • The Utility of the MAUDE Database for Osseointegrated Auditory Implants. Coelho, Daniel H.; Tampio, Alex J. // Annals of Otology, Rhinology & Laryngology;Jan2017, Vol. 126 Issue 1, p61 

    Objective: To determine the utility of Manufacturer and User Friendly Device Experience (MAUDE) database in studying osseointegrated auditory implant (OAI)–related complications. Methods: The MAUDE database was searched for all reports involving OAIs (ie, Baha, Ponto, Sophono)....

  • The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk. Ellington, David R.; Richter, Holly E. // Obstetrics & Gynecology International;2013, p1 

    Synthetic transvaginal mesh has been employed in the treatment of pelvic organ prolapse for more than a decade. As the use of these devices increased during this period so did adverse event reporting. In 2008, the Food and Drug Administration (FDA) Public Health Notification informed physicians...

  • Biological and biomechanical assessment of a long-term bioresorbable silk-derived surgical mesh in an abdominal body wall defect model. Horan, R. L.; Bramono, D. S.; Stanley, J. R. L.; Simmons, Q.; Chen, J.; Boepple, H. E.; Altman, G. H. // Hernia;Apr2009, Vol. 13 Issue 2, p189 

    The patient’s own repair of a body wall defect would be enhanced by a mechanically robust, physically tailorable, bioresorbable mesh scaffold that: (1) supports rapid host tissue ingrowth and development, while (2) reducing the complications associated with permanent synthetic and...

  • Evaluation of crosslinked and non-crosslinked biologic prostheses for abdominal hernia repair. Castro Brás, L.; Shurey, S.; Sibbons, P. // Hernia;Feb2012, Vol. 16 Issue 1, p77 

    Introduction: Abdominal wall defects and incisional hernias represent a challenging problem. Currently, several commercially available biologic prostheses are used clinically for hernia repair. We compared the performance and efficacy of two non-crosslinked meshes in ventral hernia repair to two...

  • Laparoscopic repair of potentially contaminated abdominal ventral hernias using a xenograft: a case series. Parra, M.; Rodas, E.; Niravel, A. // Hernia;Oct2011, Vol. 15 Issue 5, p575 

    Background: The aim of this study was to describe the preliminary experience of definitive single stage laparoscopic reconstruction of the abdominal wall utilizing a tissue matrix in a potentially contaminated surgical field. Method: Retrospective review of potentially contaminated ventral...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics